5001842025-07-012025-09-305001842025-09-305001842025-03-315001842025-04-012025-09-305001842025-07-012025-09-30in-capmkt:OtherExpenses1Member5001842025-04-012025-09-30in-capmkt:OtherExpenses1Member5001842025-07-012025-09-30in-capmkt:ReportableSegments1Member5001842025-07-012025-09-30in-capmkt:ReportableSegments2Member5001842025-04-012025-09-30in-capmkt:ReportableSegments1Member5001842025-04-012025-09-30in-capmkt:ReportableSegments2Member5001842025-07-012025-09-30in-capmkt:ReportableSegments1Member5001842025-07-012025-09-30in-capmkt:ReportableSegments2Member5001842025-04-012025-09-30in-capmkt:ReportableSegments1Member5001842025-04-012025-09-30in-capmkt:ReportableSegments2Member5001842025-07-012025-09-30in-capmkt:ReportableSegments1Member5001842025-09-30in-capmkt:ReportableSegments1Member5001842025-07-012025-09-30in-capmkt:ReportableSegments2Member5001842025-09-30in-capmkt:ReportableSegments2Member5001842025-07-012025-09-30in-capmkt:ReportableSegments1Member5001842025-09-30in-capmkt:ReportableSegments1Member5001842025-07-012025-09-30in-capmkt:ReportableSegments2Member5001842025-09-30in-capmkt:ReportableSegments2Member5001842025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001842025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001842025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001842025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001842025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15001842025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500184HSCLNOTLISTEDINE019C01026Himadri Speciality Chemical LimitedMain BoardEquity2025-04-012026-03-312025-10-172025-10-10INRCroresQuarterlySecond quarterMulti segment2025-10-1717:30:002025-10-1718:30:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated10710300000359300000110696000007107600000281800000-769900000513800000147800000173900000124920000087042000002365400000023654000005521000005190000060400000001761400000000017614000002800000017894000001766600000-52000001795800000-640000049420000013.583.55003.583.550.00210.12220.1818(3) The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 17 October 2025. A Limited Review of these consolidated financial results for the quarter and six months ended 30 September 2025 has been carried out by the Statutory Auditors, as required under Regulation 33 and Regulation 52 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> <BR> (4) Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Rs 5.07 crores for the quarter ended 30 September 2025, Rs (9.76) crores for the quarter ended 30 June 2025, Rs (4.90) crores for the quarter ended 30 September 2024, Rs (4.70) crores for the six months ended 30 September 2025, Rs (9.21) crores for the six months ended 30 September 2024 and Rs (7.48) crores for the year ended 31 March 2025. <BR> <BR> (5) Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Group's business activity falls within two operating segments, namely: <BR> (a) Carbon materials and chemicals, and <BR> (b) Power <BR> <BR> (6) The consolidated financial results are prepared in accordance with the principles and procedures for the preparation and presentation of consolidated financial results as set out in Ind AS 110 'Consolidated Financial Statements' notified by Ministry of Corporate Affairs. <BR> The consolidated financial results of Himadri Speciality Chemical Limited (the Holding Company or the Parent), include its subsidiaries, namely AAT Global Limited, Shandong Dawn Himadri Chemical Industry Limited, Himadri Speciality Inc (w.e.f 07 February 2025), Himadri Agro Tech Specialities Limited (HATSL) (formerly Combe Projects Private Ltd. and Combe Projects Ltd.), Himadri Clean Energy Limited, Himadri Future Material Technology Limited, Invati Creations Private Limited (w.e.f 17 May 2024), Himadri Green Technologies Innovation Limited (w.e.f 01 August 2024), Birla Tyres Limited (w.e.f 01 April 2025), Himadri Birla Tyre Manufacturer Private Limited (w.e.f 01 April 2025), Trancemarine and Confreight Logistics Private Limited (w.e.f 04 April 2025), Sturdy Niketan Private Limited (w.e.f 04 April 2025) and Himadri Advance New Energy Material Limited (HANEML) (formerly, Elixir Carbo Private Ltd. and Elixir Carbo Ltd.) (w.e.f 22 April 2025) (the Holding Company or the Parent and its subsidiaries together referred to as the 'Group'), combined on a line-by-line basis by adding together the book values of like items of asset and liabilities, income and expenses eliminating intra-group balances and transactions and resulting unrealised gains/ (losses). <BR> The Holding Company has acquired 40% and 49% paid-up share capital of M/s. Invati Creations Private Limited (ICPL) and Himadri Birla Tyre Manufacturer Private Limited (HBTMPL) respectively and this voting right does not qualify ICPL and HBTMPL as a subsidiary under Section 2(87) of the Companies Act, 2013. However based on contractual rights (including potential voting right), the Holding Company has the power to make decisions concerning relevant activities and thus has control over ICPL and HBTMPL as per IND AS 110: "Consolidated Financial Statements." Consequently, the management of the Holding Company has decided to consolidate the financial results of ICPL as a subsidiary with effect from May 17, 2024 and 1 April 2025 respectively. <BR> The consolidated financial results are prepared applying uniform accounting policies on all material items. <BR> <BR> (7) On 14 May 2024, the Holding Company has issued and allotted 10,817,000 warrants, each convertible into one equity share of Re 1 each, on Preferential allotment basis at an issue price of Rs 316 per warrant, to the Promoters of the Holding Company and certain identified non-promoter persons, upon receipt of 25% of the issue price (i.e. Rs 79 per warrant) as warrant subscription money. Balance 75% of the issue price (i.e. Rs 237 per warrant) shall be payable within 18 months from the date of allotment i.e.14 May 2024, at the time of exercising the option to apply for fully paid-up equity share of Re 1 each of the Holding Company, against each warrant held by the warrant holder. <BR> <BR> During the quarter ended 30 September 2025, the Holding Company upon receipt of balance 75% of the issue price (i.e., Rs 237 per warrant) for 308,000 warrants, has allotted equal no. of fully paid-up equity shares against conversion of said warrants exercised by the warrant holder. As a result of such allotment, the paid-up equity share capital of the Holding Company has increased from 493,849,499 equity shares to 494,157,499 equity shares of face value of Re 1 each. <BR> <BR> (8) The Nomination and Remuneration Committee of the Holding Company at its meeting held on 20 September 2025, has allotted 12,451 equity shares of Re 1 each (Under Grant II) to the option grantees pursuant to exercise of options under the Holding Company’s “Himadri Employee Stock Option Plan 2016”. As a result of such allotment, the paid up equity share capital of the Holding Company has increased from 494,157,499 equity shares to 494,169,950 equity shares of face value of Re 1 each. <BR> <BR> (9) Subsequent to the period ended 30 September 2025, the Holding Company upon receipt of balance 75% of the issue price (i.e., Rs 237 per warrant) for 307,800 warrants, has allotted equal no. of fully paid-up equity shares against conversion of said warrants exercised by the warrant holder. As a result of such allotment, the paid-up equity share capital of the Holding Company has increased from 494,169,950 equity shares to 494,477,750 equity shares of face value of Re 1 each. <BR> <BR> For the remaining 10,041,200 warrants, the respective allottees have not yet exercised their option for conversion of the warrants into equity shares and accordingly, balance 75% money towards such remaining warrants is yet to be received.The last day for exercising the option for conversion of the warrants into equity shares of the Holding Company is 13 November 2025, being 18 months from the date of allotment of warrants i.e., 14 May 2024. <BR> <BR> (10) Effective 01 April 2025 the Holding Company has migrated to the Lower Tax Regime as prescribed under section 115BAA of the Income Tax Act 1961, introduced by the Taxation Laws (Amendment) Act, 2019. The Holding Company had during the previous year, re-assessed the carrying value of deferred tax assets/ Liability and took a reversal of deferred tax liability of Rs 3.01 Crores during the quarter and year ended 31 March 2025 on account of deferred tax to be reversed during lower tax regime. The Holding Company had also charged to deferred tax liability, unutilised MAT of Rs 3.57 Crores during the quarter and year ended 31 March 2025 as the same is not eligible to be set off during lower tax Regime. <BR> <BR> (11) During the quarter ended 30 September 2025, the Holding Company has issued commercial papers which were listed on the BSE pursuant to SEBI Master Circular No SEBIIHOIDDHS/PoDUP/CIR/2024154 dated 22 May 2024. <BR> <BR> (12) Earnings per share is not annualised for the quarter ended 30 September 2025, 30 June 2025, 30 September 2024, six months ended 30 September 2025 and 30 September 2024. <BR> <BR> <BR> 2025-04-012025-09-30UnauditedConsolidated218932000006261000002251930000014364400000339000000-989400000925000000306100000320300000247630000017741700000477760000004777600000116170000060900000122260000003555000000000035550000004530000036003000003583500000-285000003630600000-3030000049420000017.267.2007.267.20.00210.12140.1765Other Expenses1249200000Other Expenses2476300000152560000004429100000024430000011342000006815700000101800000012250000008142500000131000000370800000297079000007411100000417300000602280000069100000058271000007120000042990000013459300000459840000025468800000551767000004942000004019560000040689800000274400000409642000005627000000003600000059870000011840000027191000003436200000803500000033300000162670000016600000006687000001036370000013190000022900000257800000107763000001421250000055176700000 Other unallocable expenses net of unallocable income includes other income and foreign exchange loss/ (gain) (net), fully unallocableCarbon materials and chemicals10672100000Power229000000Carbon materials and chemicals21800600000Power48440000010901100000222850000001908000003918000001071030000021893200000Carbon materials and chemicals2013100000Power191500000Carbon materials and chemicals3997800000Power41290000022046000004410700000147800000306100000-308600000-67300000023654000004777600000Carbon materials and chemicals38830600000Power1007600000398382000001533850000055176700000Carbon materials and chemicals2425800000Power540000024312000001178130000014212500000Other unallocable expenses net of unallocable income includes other income and foreign exchange loss/ (gain) (net), fully unallocable306100000-15534000004730000000-26910000045000000-29744000000-78000000006500000032030000000086600000072900000026830000000000-1136000000-46889000008870000000010373000000-94860000000000000343000001806500000024748000000300000000000000000001177000000-509700000-46393000000007300000000112000000534900000-474650000078000002963000003175000000-275000004716500000-8714000000-8714000001562400000691000000Remeasurements of the net defined benefit plan-500000Net gain/ (loss) on investment in equity instruments accounted at fair value-10000000-10500000Remeasurements of the net defined benefit plan-1000000Net gain/ (loss) on investment in equity instruments accounted at fair value47000003700000-1500000-2900000Exchange differences in translating financial statements of foreign operations3700000037000000Exchange differences in translating financial statements of foreign operations3870000038700000002800000045300000